Senti Biosciences Holdings, Inc. (SNTI)
0.3868
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 16:00
0.3868
0.00 (0.00%)
After-Hours: 20:00
Senti Biosciences Holdings Shareholders Equity (Quarterly) : -3.401M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.401M |
| March 31, 2026 | 2.565M |
| December 31, 2025 | 5.589M |
| September 30, 2025 | 8.121M |
| June 30, 2025 | 24.65M |
| March 31, 2025 | 37.86M |
| December 31, 2024 | 50.76M |
| September 30, 2024 | 15.99M |
| June 30, 2024 | 44.15M |
| March 31, 2024 | 56.09M |
| December 31, 2023 | 66.91M |
| Date | Value |
|---|---|
| September 30, 2023 | 82.94M |
| June 30, 2023 | 97.42M |
| March 31, 2023 | 112.34M |
| December 31, 2022 | 127.26M |
| September 30, 2022 | 140.34M |
| June 30, 2022 | 154.27M |
| March 31, 2022 | 219.81M |
| December 31, 2021 | 60.38M |
| September 30, 2021 | 223.48M |
| June 30, 2021 | 223.77M |
| March 31, 2021 | 0.0238M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovelStem International Corp. | -2.032M |
| Brainstorm Cell Therapeutics, Inc. | -11.60M |
| Summit Therapeutics, Inc. | 629.98M |
| Kezar Life Sciences, Inc. | 65.24M |
| Protara Therapeutics, Inc. | 161.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 33.10M |
| Total Liabilities (Quarterly) | 36.51M |
| Debt to Equity Ratio | -5.947 |
| Current Ratio | 0.8251 |
| Net Debt Paydown Yield | 7.13% |